Literature DB >> 17305473

Molecular mechanisms and therapeutic reversal of immune suppression in cancer.

Dmitry I Gabrilovich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17305473

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN： 1568-0096            Impact factor:   3.428


× No keyword cloud information.
  13 in total

1.  The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.

Authors:  Przemyslaw Juszczynski; Jing Ouyang; Stefano Monti; Scott J Rodig; Kunihiko Takeyama; Jeremy Abramson; Wen Chen; Jeffery L Kutok; Gabriel A Rabinovich; Margaret A Shipp
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

Review 2.  Immune regulation by non-lymphoid cells in transplantation.

Authors:  A-S Dugast; B Vanhove
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

3.  Receptor desensitization and blockade of the suppressive effects of prostaglandin E(2) and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes.

Authors:  Yunyun Su; Edwin K Jackson; Elieser Gorelik
Journal:  Cancer Immunol Immunother       Date:  2010-10-20       Impact factor: 6.968

Review 4.  Rebuilding immunity in cancer patients.

Authors:  Stanimir Vuk-Pavlovic
Journal:  Blood Cells Mol Dis       Date:  2007-09-10       Impact factor: 3.039

5.  An active form of sphingosine kinase-1 is released in the extracellular medium as component of membrane vesicles shed by two human tumor cell lines.

Authors:  Salvatrice Rigogliuso; Chiara Donati; Donata Cassarà; Simona Taverna; Monica Salamone; Paola Bruni; Maria Letizia Vittorelli
Journal:  J Oncol       Date:  2010-05-24       Impact factor: 4.375

6.  PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer.

Authors:  Sudeep K Bose; Willietta Gibson; Rebecca S Bullard; Carlton D Donald
Journal:  Mol Immunol       Date:  2008-12-31       Impact factor: 4.407

Review 7.  The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer.

Authors:  Rindert Missiaen; Massimiliano Mazzone; Gabriele Bergers
Journal:  Semin Cancer Biol       Date:  2018-06-20       Impact factor: 15.707

8.  IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease.

Authors:  Robert Sucher; Katharina Kurz; Guenter Weiss; Raimund Margreiter; Dietmar Fuchs; Gerald Brandacher
Journal:  Int J Tryptophan Res       Date:  2010-06-10

9.  Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent.

Authors:  Sylvia Feyler; Gina B Scott; Christopher Parrish; Sarah Jarmin; Paul Evans; Mike Short; Katherine McKinley; Peter J Selby; Gordon Cook
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

10.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.